Literature DB >> 448065

Antibody responses to vaccination with WRL 105 strain live influenza vaccine in previously vaccinated and unvaccinated volunteers.

A E Evans, R L Simmons, R D Ferris, S K Hasell, E Letley, D S Freestone.   

Abstract

Intranasal vaccination with a single 0.5 ml dose of 10(7.0) EID 50 WRL 105 strain live influenza vaccine elicited four-fold or greater increases in circulating homotypic haemagglutinating inhibiting (HAI) antibody in 60 (64.5%) of 93 volunteers, or in 58 (74.4%) of 78 volunteers with HAI antibody titres before vaccination of less than or equal to 1/20. In comparison, in a group of volunteers vaccinated 9 months previously re-vaccination elicited antibody responses in only 4 (6.9%) of 58 volunteers, or in 3 (14.3%) of 21 volunteers with antibody titres before vaccination of less than or equal to 1/20. Titres of vaccine-induced antibody and antibody resulting from earlier natural infection appeared to fall slowly and at equivalent rates over a 9 month period.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 448065      PMCID: PMC2130072          DOI: 10.1017/s0022172400054012

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  11 in total

1.  Application of a microtechnique to viral serological investigations.

Authors:  J L SEVER
Journal:  J Immunol       Date:  1962-03       Impact factor: 5.422

2.  WRL 105 strain live attenuated influenza vaccine; comparison of one and two dose schedules.

Authors:  A E Evans; E Letley; R D Ferris; D S Freestone
Journal:  J Hyg (Lond)       Date:  1976-12

3.  A clinical trial of WRL 105 strain live attenuated influenza vaccine comparing four methods of intranasal vaccination.

Authors:  D S Freestone; C H Bowker; E Letley; R D Ferris; W G White; G M Barnes
Journal:  J Hyg (Lond)       Date:  1976-06

4.  Preparation and characterization of live recombinant influenza vaccine.

Authors:  V M Stealey; D McCahon; D S Freestone
Journal:  Dev Biol Stand       Date:  1976

5.  Differential response of ferrets to infection with virulent and avirulent influenza viruses: a possible marker of virus attenuation.

Authors:  R J Fenton; R Jennings; C W Potter
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

6.  Assessment of elicited antibody responses, clinical reactions and transmissibility of WRL 105 live influenza vaccine.

Authors:  M A Moffat; V M Stealey; D S Freestone; A Macdonald
Journal:  J Biol Stand       Date:  1976-04

7.  Detection of attenuation of recombinant influenza viruses in vitro.

Authors:  S R Mostow; D A Tyrrell
Journal:  Lancet       Date:  1972-07-15       Impact factor: 79.321

8.  Clinical trials with intranasally administered WRL 105 strain live influenza vaccine in volunteers.

Authors:  D S Freestone
Journal:  Dev Biol Stand       Date:  1976

9.  Antibody responses and resistance to challenge in volunteers vaccinated with live attenuated, detergent split and oil adjuvant A2-Hong Kong-68 (H 3 N 2 ) influenza vaccines. A report to the Medical Research Council Committee on Influenza and other Respiratory Virus Vaccines.

Authors:  D S Freestone; S Hamilton-Smith; G C Schild; R Buckland; S Chinn; D A Tyrrell
Journal:  J Hyg (Lond)       Date:  1972-09

10.  Recombinant WRL 105 strain live attenuated influenza vaccine. Immunogenicity, reactivity, and transmissibility.

Authors:  C A Morris; D S Freestone; V M Stealey; P R Oliver
Journal:  Lancet       Date:  1975-08-02       Impact factor: 79.321

View more
  2 in total

Review 1.  Pathogenicity of influenza virus.

Authors:  C Sweet; H Smith
Journal:  Microbiol Rev       Date:  1980-06

2.  Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children.

Authors:  Bruce D Forrest; Michael W Pride; Andrew J Dunning; Maria Rosario Z Capeding; Tawee Chotpitayasunondh; John S Tam; Ruth Rappaport; John H Eldridge; William C Gruber
Journal:  Clin Vaccine Immunol       Date:  2008-04-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.